Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden
A nationwide cohort study in Sweden suggests long-term proton pump inhibitor (PPI) use might be an independent risk factor for gastric cancer,... Read More
Increased Oral Pathogens and Decreased Bacterial Diversity Predict Precancerous Lesions of Stomach Cancer
New research out of NYU shows an increase in pathogens associated with periodontal disease and a decrease in bacterial diversity in the... Read More
Expression of annexin II in gastric carcinoma and its role in gastric cancer metastasis.
A new study finds high expression of annexin II could promote the invasion and metastasis of gastric cancer.
Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study
A new study in GUT found the long-term use of proton pump inhibitors was still associated with an increased gastric cancer risk... Read More
Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial
While a phase III study did not find a significant improvement in overall survival of Asian patients with advanced #StomachCancer treated with... Read More
Impact of Neoadjuvant Chemoradiotherapy on Health Related Quality of Life In Long-Term Survivors of Esophageal or Junctional Cancer: Results from the Randomized Cross Trial
A new study is out on quality-of-life measures for survivors who received neoadjuvant therapy versus surgery, suggesting that neoadjuvant chemoradiotherapy can be... Read More
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
A phase III randomized controlled trial published in The Lancet evaluated the efficacy of the PD-1 inhibitor Nivolumab in patients with previously... Read More
Silibinin inhibits the migration and invasion of human gastric cancer SGC7901 cells by downregulating MMP‑2 and MMP‑9 expression via the p38MAPK signaling pathway
Researchers find silibinin inhibits the migration and invasion of gastric cancer SGC7901 cells by downregulating MMP‑2 and MMP‑9 expression by the p38MAPK... Read More
Nut and peanut butter consumption and the risk of esophageal and gastric cancer subtypes.
A new study explores the link between nut consumption and lowering the risk of esophageal and gastric cancers, particularly for older adults.
Clinicopathological features and prognoses in younger and older patients with gastric cancer
A Dove Press study explores the differences in clinicopathological prognoses and features in younger and older patients with gastric cancer.